US Patent Issued to Zhejiang Gongshang University on April 29 for "Lactiplantibacillus plantarum effectively inhibiting multi-drug-resistant Klebsiella pneumoniae and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,450, issued on April 29, was assigned to Zhejiang Gongshang University (Hangzhou, China).

"Lactiplantibacillus plantarum effectively inhibiting multi-drug-resistant Klebsiella pneumoniae and use thereof" was invented by Qing Gu (Zhejiang, China), Yingjuan Zhang (Zhejiang, China), Qingqing Zhou (Zhejiang, China), Zhongdu Ye (Zhejiang, China) and Ping Li (Zhejiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A Lactiplantibacillus plantarum strain ZFM518 deposited under CCTCC NO: M 2022442 is provided. Also provided is a composition including the strain ZFM518. Further provided is a method of treating a subject infected by Klebsiella pneumoniae...